RepliCel Life Sciences
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
570 Granville St Ste 900, Vancouver, Bri...Phone Number
(604) 248-8730Website
www.replicel.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About RepliCel Life Sciences
RepliCel Life Sciences is a regenerative medicine company specializing in autologous cell therapies aimed at treating conditions related to the lack of healthy cells necessary for healing and proper function. The company has developed DermaPrecise, a next-generation dermal injector that enhances control and precision for intradermal and subcutaneous injections. Their products, including RCT-01, RCS-01, and RCH-01, focus on tendon repair, skin rejuvenation, and hair growth, respectively. RepliCel serves patients seeking innovative treatments, partners in the healthcare sector, and investors interested in regenerative medicine advancements.Explore more
RepliCel Life Sciences Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RepliCel Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at RepliCel Life Sciences
Check if RepliCel Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if RepliCel Life Sciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on RepliCel Life Sciences recently announced quarterly report
Funding: Get notified immidiatlly once RepliCel Life Sciences has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when RepliCel Life Sciences launches new products
Check out if RepliCel Life Sciences is spiking on competitors!
RepliCel Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined RepliCel Life Sciences as Masked Content
Find 3 more new buyers
Compare Similar Companies to RepliCel Life Sciences
Compare insights from companies similar to RepliCel Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RepliCel Life Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
RepliCel Life Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about RepliCel Life Sciences.
RepliCel Life Sciences Tech Stack
A closer look at the technologies used by RepliCel Life Sciences
RepliCel Life Sciences News & Media
DermaPrecise(TM) Injection System Shown to Produce Consistently High Cell Count and Viability for Cell Therapy Injections
RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, announced today it has received test results showing that cells injected through the DermaPrecise™ Injector maintained >99% viability.CORRECTION: Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
RepliCel Life Sciences Inc. (OTC PINK:REPCF) (TSXV:RP) (FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, announced today it has now received and analyzed all data and images from independent laboratory testing of the DermaPreciseTM injector prototype and consumables evaluating the injection systems' various depths and doses in donated human skin tissue*.RepliCel Announces Dermal Injector Update
Testing progresses to next-phase; results lead to some component upgrades to ensure optimal performance, quality compliance, and commercial-scale production capabilitiesVANCOUVER, BC / ACCESSWIRE / October 27, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, provided an update on its dermal injector program.RepliCel Applies for Manufacturing Approval for Its Collagen and Tissue Regeneration Cell Therapies
Clinical development of RepliCel's skin rejuvenation and tendon regeneration injectables continues to meet milestones on path to commercialization in JapanVANCOUVER, BC / ACCESSWIRE / July 7, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FSE:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce it has submitted its application to Japan's Ministry of Health, Labour, and Welfare (MHLW) for approva
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding RepliCel Life Sciences
Sign Up For FreeTo access detailed company insights
RepliCel Life Sciences is a regenerative medicine company specializing in autologous cell therapies aimed at treating conditions related to the lack of healthy cells necessary for healing and proper function. The company has developed DermaPrecise, a next-generation dermal injector that enhances control and precision for intradermal and subcutaneou... Read More
